Cargando…

Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis

BACKGROUND: Radiofrequency ablation (RFA) can not only effectively kill hepatocellular carcinoma (HCC) tumour cells but also release tumour antigens that can provoke an immune response. However, there is no consensus regarding which antigens could constitutively be generated after RFA and could pote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Shunli, Peng, Hong, Wang, Ye, Xu, Ming, Lin, Manxia, Xie, Xiaoyan, Peng, Baogang, Kuang, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793368/ https://www.ncbi.nlm.nih.gov/pubmed/29386009 http://dx.doi.org/10.1186/s12885-018-4011-8

Ejemplares similares

Combinatory local ablation and immunotherapies for hepatocellular carcinoma: Rationale, efficacy, and perspective
por: Chen, Shuling, et al.
Publicado: (2022)

Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma
por: Xu, Yun, et al.
Publicado: (2017)

Long-term outcomes of combined radiofrequency ablation and multipronged ethanol ablation for the treatment of unfavorable hepatocellular carcinoma
por: Liu, Ming, et al.
Publicado: (2023)

Multiple-Electrode Switching-Based Radiofrequency Ablation vs. Conventional Radiofrequency Ablation for Single Early-Stage Hepatocellular Carcinoma Ranging From 2 to 5 Cm
por: Huang, Guang-liang, et al.
Publicado: (2020)

Percutaneous radiofrequency ablation of adrenal metastases from hepatocellular carcinoma: a single-center experience
por: Huang, Jingzhi, et al.
Publicado: (2019)

Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma
por: Kwak, Min Hwan, et al.
Publicado: (2022)

Radiofrequency ablation versus hepatic resection for recurrent hepatocellular carcinoma: an updated meta-analysis
por: Yang, Daopeng, et al.
Publicado: (2020)

The role of associating liver partition and portal vein ligation for staged hepatectomy in unresectable hepatitis B virus-related hepatocellular carcinoma
por: Ke, Lixin, et al.
Publicado: (2020)

Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma
por: Shen, Rui, et al.
Publicado: (2022)

Radiofrequency Thermal Ablation of Hepatocellular Carcinomas
por: Lim, Hyo Keun
Publicado: (2000)

Four Immune-Related Long Non-coding RNAs for Prognosis Prediction in Patients With Hepatocellular Carcinoma
por: Li, Muqi, et al.
Publicado: (2020)

Effects of intratumoral injection of immunoactivator after microwave ablation on antitumor immunity in a mouse model of hepatocellular carcinoma
por: Wu, Hao, et al.
Publicado: (2018)

Therapeutic Efficacy of Percutaneous Radiofrequency Ablation versus Microwave Ablation for Hepatocellular Carcinoma
por: Zhang, Lei, et al.
Publicado: (2013)

Radiofrequency ablation induces tumor cell dissemination in a mouse model of hepatocellular carcinoma
por: Zhuang, Bowen, et al.
Publicado: (2023)

Somatic Mutation Profiles Revealed by Next Generation Sequencing (NGS) in 39 Chinese Hepatocellular Carcinoma Patients
por: Ke, Lixin, et al.
Publicado: (2022)

Radiofrequency ablation combined with toripalimab for recurrent hepatocellular carcinoma: A prospective controlled trial
por: Wen, Zhenyu, et al.
Publicado: (2023)

The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma
por: Xu, Zhentian, et al.
Publicado: (2019)

Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response
por: Qi, Xiaoqiang, et al.
Publicado: (2020)

Use of radiofrequency ablation in the treatment of hepatocellular carcinoma: Experience of ablation protocols
por: MASAYOSHI, TAKAHASHI, et al.
Publicado: (2012)

Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation
por: Chen, Jinbin, et al.
Publicado: (2018)

Percutaneous radiofrequency ablation is superior to hepatic resection in patients with small hepatocellular carcinoma
por: Zhang, Yan-Hua, et al.
Publicado: (2020)

Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation
por: Uchino, Koji, et al.
Publicado: (2018)

Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas: a systematic review and meta-analysis
por: Luo, Wen, et al.
Publicado: (2017)

Radiofrequency Ablation of Hepatocellular Carcinoma: A Literature Review
por: Minami, Yasunori, et al.
Publicado: (2011)

Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma
por: Himoto, Takashi, et al.
Publicado: (2012)

An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation
por: Guo, Yusheng, et al.
Publicado: (2022)

Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma
por: Feng, Qingbo, et al.
Publicado: (2022)

Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma
por: Kawaguchi, Yoshikuni, et al.
Publicado: (2023)

Six Metabolism Related mRNAs Predict the Prognosis of Patients With Hepatocellular Carcinoma
por: Wu, Xiwen, et al.
Publicado: (2021)

Risk predictive model based on three immune-related gene pairs to assess prognosis and therapeutic sensitivity for hepatocellular carcinoma
por: Qian, Baifeng, et al.
Publicado: (2022)

The prognostic value of neuromedin U in patients with hepatocellular carcinoma
por: Li, Qiao, et al.
Publicado: (2020)

Combined Transarterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Infeasible for Ultrasound-Guided Percutaneous Radiofrequency Ablation: A Comparative Study with General Ultrasound-Guided Radiofrequency Ablation Outcomes
por: Cha, Dong Ik, et al.
Publicado: (2023)

Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research
por: Wu, Shilun, et al.
Publicado: (2022)

NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition
por: Zhang, Yi, et al.
Publicado: (2018)

Cost-Effectiveness Analysis of Follow-Up Schedule for Hepatocellular Carcinoma after Radiofrequency Ablation
por: Hu, Shuifang, et al.
Publicado: (2022)

Quantitative proteomic analysis for high-throughput screening of differential glycoproteins in hepatocellular carcinoma serum
por: Gao, Hua-Jun, et al.
Publicado: (2015)

Management of Spontaneously Ruptured Hepatocellular Carcinomas in the Radiofrequency Ablation Era
por: Cheung, Tan To, et al.
Publicado: (2014)

Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience
por: Kalra, Naveen, et al.
Publicado: (2013)

EUS-guided radiofrequency ablation of a hepatocellular carcinoma of the liver
por: Attili, Fabia, et al.
Publicado: (2018)

Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma
por: Kang, Tae Wook, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ga8pso98hdnnm1kqva1llr5i91